We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$123M
Cap. Flow
-$889M
Cap. Flow %
-0.34%
Top 10 Hldgs %
14.45%
Holding
8,655
New
737
Increased
4,061
Reduced
2,893
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 9.47%
2 Financials 6.72%
3 Healthcare 6.27%
4 Consumer Discretionary 5.76%
5 Industrials 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNJN
7001
DELISTED
Finjan Holdings, Inc.
FNJN
$13K ﹤0.01%
6,512
-614
-9% -$1.26K
GPAQU
7002
DELISTED
Gordon Pointe Acquisition Corp. Unit
GPAQU
$13K ﹤0.01%
1,254
PBBI
7003
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$13K ﹤0.01%
1,160
+1,041
+875% +$11.9K
TMCXW
7004
DELISTED
Trinity Merger Corp. Warrant
TMCXW
$13K ﹤0.01%
+10,103
New +$5.76K
VISL
7005
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$13K ﹤0.01%
212
+202
+2,020% +$25.7K
MACK
7006
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$13K ﹤0.01%
2,755
+1,996
+263% +$9.97K
HEWY
7007
DELISTED
iShares Currency Hedged MSCI South Korea ETF
HEWY
$13K ﹤0.01%
530
-230
-30% -$5.66K
PLM
7008
DELISTED
PolyMet Mining Corp.
PLM
$13K ﹤0.01%
4,286
+1,679
+64% +$6.27K
CPI
7009
DELISTED
CPI Inflation Hedged ETF
CPI
$13K ﹤0.01%
458
+168
+58% +$4.69K
ABTS icon
7010
Abits Group
ABTS
$3.17M
$12K ﹤0.01%
+429
New +$11.8K
AFIF icon
7011
Anfield Universal Fixed Income ETF
AFIF
$227M
$12K ﹤0.01%
1,282
-406
-24% -$3.97K
CIG.C icon
7012
CEMIG Ordinary Shares
CIG.C
$8.95B
$12K ﹤0.01%
5,572
-338
-6% -$866
CPSS icon
7013
Consumer Portfolio Services
CPSS
$207M
$12K ﹤0.01%
3,389
+1,927
+132% +$6.96K
CRD.B icon
7014
Crawford & Co Class B
CRD.B
$514M
$12K ﹤0.01%
1,215
+130
+12% +$1.22K
CRDF icon
7015
Cardiff Oncology
CRDF
$71.1M
$12K ﹤0.01%
7,707
+2,939
+62% +$5.72K
DAIO icon
7016
Data I/O
DAIO
$29.8M
$12K ﹤0.01%
3,206
+3,057
+2,052% +$12.3K
EQ icon
7017
Equillium
EQ
$139M
$12K ﹤0.01%
3,167
+2,264
+251% +$9.73K
FLRT icon
7018
Pacer Aristotle Pacific Floating Rate High Income ETF
FLRT
$660M
$12K ﹤0.01%
241
-120
-33% -$5.87K
GHG
7019
GreenTree Hospitality
GHG
$114M
$12K ﹤0.01%
1,197
-744
-38% -$8.42K
INTT icon
7020
inTEST
INTT
$169M
$12K ﹤0.01%
+2,680
New +$12K
LRMR icon
7021
Larimar Therapeutics
LRMR
$401M
$12K ﹤0.01%
+1,342
New +$14.7K
MBRX icon
7022
Moleculin Biotech
MBRX
$2.61M
$12K ﹤0.01%
+5
New +$12.9K
BINI
7023
DELISTED
Bollinger Innovations
BINI
0
MYO icon
7024
Myomo
MYO
$41.7M
$12K ﹤0.01%
+663
New +$15.1K
NOA
7025
North American Construction
NOA
$368M
$12K ﹤0.01%
1,000
-3,721
-79% -$42.6K

Similar funds

UBS Group's Q3 2019 Portfolio in Review

As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2019 filing shows 737 new, 4,061 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
  • UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
  • UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
  • UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
  • UBS Group opened 737 new positions and closed 594 in Q3 2019.
  • UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.